医学
哮喘
哮喘管理
结果(博弈论)
完全缓解
重症监护医学
儿科
内科学
化疗
数学
数理经济学
作者
Márcia Margaret Menezes Pizzichini,Emílio Pizzichini
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2024-12-01
卷期号:64 (6): 2401908-2401908
标识
DOI:10.1183/13993003.01908-2024
摘要
Extract In recent years, with the introduction of biologic therapies for the treatment of severe asthma, there has been a shift in the goals of asthma management, from control to remission; although remission is not a cure, it is a meaningful, relevant patient-oriented outcome [1]. However, the definition of asthma remission is evolving [2] and varies across studies [3–5]. In addition, the associated factors and determinants of asthma remission are not yet completely understood. Nevertheless, there is no doubt that remission (irrespective of its definition) can be achieved in a proportion of patients with severe asthma under treatment with biologics [3–5], something until recently deemed unattainable.
科研通智能强力驱动
Strongly Powered by AbleSci AI